This study examined the proportion of hospitalizations associated with adverse medication events (AMEs) for adults with intellectual and developmental disabilities (IDD) and adults from the general population in the United States using the 2013 National Inpatient Sample (NIS) dataset of the Healthcare Cost and Utilization Project (HCUP). Adults with IDD had greater odds of having a hospitalization associated with an AME than the general adult population. Unadjusted odds ratios (95% CI) for hospitalization due to any medication for IDD was 2.47 (2.31-2.65). In the multivariate logistic regression model, IDD was significantly associated, with an odds ratio of 1.28 (1.19-1.38). Adults who have IDD are at greater risk of having a hospital admission due to an AME.

中文翻译：

---

美国与住院有关的不良用药事件：智力和发育障碍的成年人与没有智力障碍和发育障碍的成年人之间的比较

这项研究使用2013年医疗费用和医疗费用的全国住院样本（NIS）数据集，对美国智力和发育障碍（IDD）成年人以及美国普通人群的成年人与不良药物事件（AMEs）相关的住院治疗比例利用项目（HCUP）。与一般成人相比，IDD成年人与AME相关的住院治疗的可能性更大。因使用IDD的任何药物而导致住院的未调整优势比（95％CI）为2.47（2.31-2.65）。在多元逻辑回归模型中，IDD显着相关，优势比为1.28（1.19-1.38）。由于AME，IDD的成年人住院的风险更大。